Literature DB >> 19546106

Epidemiology and pathophysiology of falls in facioscapulohumeral disease.

C G C Horlings1, M Munneke, A Bickerstaffe, L Laverman, J H J Allum, G W A M Padberg, B R Bloem, B G M van Engelen.   

Abstract

BACKGROUND AND AIMS: Muscle weakness is a potentially important, yet poorly studied, risk factor for falls. Detailed studies of patients with specific myopathies may shed new light on the relation between muscle weakness and falls. Here falls in patients with facioscapulohumeral disease (FSHD) who suffered from lower limb muscle weakness were examined. This study provides insights into the prevalence, relevance and pathophysiology of falls in FSHD.
METHODS: A validated questionnaire was used as well as a prospective 3 month follow-up to examine the prevalence, circumstances and consequences of falls in 73 patients with FSHD and 49 matched healthy controls. In a subgroup of 28 subjects, muscle strength was also examined and balance was assessed electrophysiologically using body worn gyroscopes.
RESULTS: In the questionnaire, 30% of the patients reported falling at least once a month whereas none of the controls did. Injuries occurred in almost 70% of the patients. The prospective study showed that patients fell mostly at home, mainly due to intrinsic (patient related) causes, and usually in a forward direction. Fallers were unstable while climbing stairs, rising from a chair and standing with eyes closed whereas non-fallers had normal balance control. Frequent fallers had greater muscle weakness than infrequent fallers.
CONCLUSION: These findings demonstrate the high prevalence and clinical relevance of falls in FSHD. The relation between muscle weakness and instability among fallers is also highlighted. Because patients fell mainly at home, fall prevention strategies should focus on home adaptations. As mainly intrinsic causes underlie falls, the impact of adopting balance strategies or balance training should be explored in this patient group.

Entities:  

Mesh:

Year:  2009        PMID: 19546106     DOI: 10.1136/jnnp.2009.173534

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  High-intensity interval training in facioscapulohumeral muscular dystrophy type 1: a randomized clinical trial.

Authors:  Grete Andersen; Karen Heje; Astrid Emile Buch; John Vissing
Journal:  J Neurol       Date:  2017-05-03       Impact factor: 4.849

2.  Camptocormia phenotype of FSHD: a clinical and MRI study on six patients.

Authors:  Berit Jordan; Katharina Eger; Sabrina Koesling; Stephan Zierz
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

3.  Risk of fracture in patients with muscular dystrophies.

Authors:  S Pouwels; A de Boer; H G M Leufkens; W E J Weber; C Cooper; H A W van Onzenoort; F de Vries
Journal:  Osteoporos Int       Date:  2013-08-15       Impact factor: 4.507

4.  Symptom burden in persons with myotonic and facioscapulohumeral muscular dystrophy.

Authors:  Amanda E Smith; Kara McMullen; Mark P Jensen; Gregory T Carter; Ivan R Molton
Journal:  Am J Phys Med Rehabil       Date:  2014-05       Impact factor: 2.159

5.  Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial.

Authors:  Nicoline B M Voet; Gijs Bleijenberg; George W Padberg; Baziel G M van Engelen; Alexander C H Geurts
Journal:  BMC Neurol       Date:  2010-06-30       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.